Kejari Bagisi Nama Tersangka Dugaan Korupsi Keuangan RSUD Mukomuko, Announcement Tunggu Nominal Kerugian Negara

BENGKULU - Investigators of the Mukomuko District Attorney's Office (Kejari) have pocketed a number of names leading to a suspect in the alleged corruption case in the financial management of the Mukomuko Regional General Hospital (RSUD) in Bengkulu. "This August, there are already a number of names that lead to the suspect, but we have not yet determined them because we are still waiting for the calculation of state losses," said Head of the Mukomuko Kejari Rudi Iskandar in Mukomuko, Friday, August 4, confiscated by Antara. He said his institution is still waiting for the results of the calculation of state losses from the alleged corruption case of the Mukomuko Hospital budget. Kajari estimates that the number of potential suspects in the alleged corruption case of the Mukomuko Hospital budget is more than three people. They are the main perpetrators in the alleged corruption that occurred from 2016 to 2021. Prior to the determination of the suspect in the RSUD budget corruption, Kejari Mukomuko will again summon the former Director of Mukomuko Hospital who served from 2016-2021. "In the near future they were summoned and asked for information regarding the alleged corruption in the RSUD budget," he also said. Head of the Special Investigation Unit of the Attorney General's Office, Malik Rahman Hakim, said the investigators had previously examined as well as the head of the drug supply company. He said investigators conducted an examination of the head of drug suppliers to find out the sales factor and orders for drugs requested by the RSUD.

Agung explained that in the process of ordering this drug, the management of the Mukomuko Hospital was carried out directly and there were also those who shopd using the e-catalog system. For the type of order of the Mukomuko Hospital, ranging from generic drugs to medical devices with the average results of previous drug supplier examinations that had undergone examinations. "Although the drugs have been ordered by the RSUD, they have not paid them yet and are still in debt. "The evidence of orders does exist and there are also debts, but it must be proven by drug suppliers first because the time they are examined they have not brought such invoices and evidence," he said. Aggung said from 2016 to December 2021, the total state loss which was originally estimated at Rp. 1 billion, swelled to around Rp. 2.5 billion.